ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.

Asymchem Laboratories (Tianjin) Co., Ltd.

002821

CNE100002BZ6

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
66.78 ^CNY	+0.39%		+4.41%	-42.48%

Jul. 11	Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to 107.91 Yuan From 118.48 Yuan, Keeps at Buy	MT
Jul. 11	Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$76.45 From HK$83.94, Keeps at Buy	MT

Asymchem Laboratories Co., Ltd. Proposes Final Ordinary Dividend for the Year Ended 31 December 2023

March 28, 2024 at 06:49 am EDT

Asymchem Laboratories (Tianjin) Co., Ltd. proposed final ordinary dividend for the year ended 31 December 2023 of RMB 18 per 10 shares. Date of shareholders' approval is 06 June 2024. Ex-dividend date is 13 June 2024.

Record date is 24 June 2024.

Latest news about Asymchem Laboratories (Tianjin) Co., Ltd.

Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to 107.91 Yuan From 118.48 Yuan, Keeps at Buy	Jul. 11	MT
Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$76.45 From HK$83.94, Keeps at Buy	Jul. 11	MT
Asymchem Laboratories (Tianjin) Expects Up To 72% H1 Profit Drop; Shenzhen Shares Jump 9%	Jul. 10	MT
Tranche Update on Asymchem Laboratories Co., Ltd.'s Equity Buyback Plan announced on March 8, 2024.	Jul. 02	CI
Asymchem Appoints Cheng Yi Chen as CTO of Small-Molecule Sector	Jun. 26	CI
Asymchem Laboratories Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 28 June 2024	Jun. 24	CI
Asymchem Laboratories Co., Ltd. Approves Final Ordinary Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024	Jun. 06	CI
Asymchem Appoints Franck Mevellec as Senior Director, Business Development	May. 29	CI
Asymchem Laboratories Buys Pfizer's Former UK Site; Hong Kong Shares Slide 3%	May. 23	MT
China-Based Asymchem Laboratories Will Operate Former Pfizer Manufacturing Facility in UK	May. 21	DJ
Asymchem Laboratories Co., Ltd. Secures Former Pfizer Sandwich, UK, Development and API Pilot Plant Manufacturing Facilities	May. 21	CI
Asymchem Laboratories' Profit Drops 55%, Operating Income Slumps 38% in Q1; Shares Up 3%	Apr. 29	MT
Nomura Adjusts Asymchem Laboratories’ Price Target to HK$83.94 From HK$90.12 Keeps at Buy	Apr. 26	MT
Nomura Adjusts Asymchem Laboratories’ Price Target to 118.48 Yuan From 127.21 Yuan Keeps at Buy	Apr. 26	MT
Asymchem Laboratories Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Tranche Update on Asymchem Laboratories Co., Ltd.'s Equity Buyback Plan announced on March 8, 2024.	Apr. 02	CI
Asymchem Laboratories' Profit Falls 31% as Revenue Drops 24% in 2023	Mar. 29	MT
Asymchem Laboratories Co., Ltd. Proposes Final Ordinary Dividend for the Year Ended 31 December 2023	Mar. 28	CI
Asymchem Laboratories Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Asymchem Laboratories Completes A-Share Repurchase Program	Mar. 27	MT
Asymchem Laboratories Co., Ltd. commences an Equity Buyback Plan for CNY 1,200 million worth of its shares, under the authorization approved on February 29,2024.	Mar. 07	CI
Nomura Adjusts Asymchem Laboratories Tianjin’s Price Target to HK$90.12 From HK$134.59, Keeps at Buy	Mar. 04	MT
Nomura Adjusts Asymchem Laboratories (Tianjin)’s Price Target to 127.21 Yuan From 189.98 Yuan, Keeps at Buy	Mar. 04	MT
Asymchem Laboratories Co., Ltd. Appoints Hou Xinyi as an Independent Non-Executive Director, Effective 29 February 2024	Feb. 29	CI
Asymchem Laboratories Co., Ltd. Announces Resignation of Wang Qingsong as Independent Non-Executive Director and Committees	Feb. 05	CI

Chart Asymchem Laboratories (Tianjin) Co., Ltd.

Duration

Period

Chart Asymchem Laboratories (Tianjin) Co., Ltd.

More charts

Company Profile

Asymchem Laboratories Tianjin Co Ltd is a China-based company mainly engaged in providing one-stop comprehensive services for pharmaceutical outsourcing. The Company's business includes customized research and development and production of small molecule drugs (CDMO), chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output and synthetic biology. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company mainly conducts its business in domestic and foreign markets.

Sector

Pharmaceuticals

Calendar

2024-07-19 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Asymchem Laboratories (Tianjin) Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

66.78 CNY

Average target price

96.06 CNY

Spread / Average Target

+43.85%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.	-42.48%	3.15B
ELI LILLY AND COMPANY	+62.66%	854B
NOVO NORDISK A/S	+41.18%	636B
JOHNSON & JOHNSON	-4.37%	361B
MERCK & CO., INC.	+17.16%	324B
ABBVIE INC.	+9.87%	301B
ASTRAZENECA PLC	+15.55%	247B
ROCHE HOLDING AG	+6.13%	230B
NOVARTIS AG	+18.53%	228B
AMGEN INC.	+14.86%	177B

Other Pharmaceuticals

Asymchem Laboratories (Tianjin) Co., Ltd.

Equities

002821

CNE100002BZ6

Pharmaceuticals

Asymchem Laboratories Co., Ltd. Proposes Final Ordinary Dividend for the Year Ended 31 December 2023

Latest news about Asymchem Laboratories (Tianjin) Co., Ltd.

Chart Asymchem Laboratories (Tianjin) Co., Ltd.

Company Profile

Income Statement Evolution

Ratings for Asymchem Laboratories (Tianjin) Co., Ltd.

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Pharmaceuticals